[Infection in Children with Acute Myeloid Leukemia in the Intensive Chemotherapy Period]

Kai Lan Chen1, Hao Xiong1, Jian Xin Li1

  • 1Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, Hubei Province, China.

Insights

Children with acute myeloid leukemia (AML) experience high infection rates during chemotherapy. Bloodstream infections, often caused by Gram-negative bacteria, are a major concern, necessitating antifungal use.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Hematology

Background:

  • Acute myeloid leukemia (AML) is a serious hematologic malignancy in children.
  • High-intensity chemotherapy regimens are crucial for AML treatment but significantly increase infection risk.
  • Understanding infection patterns is vital for improving outcomes in pediatric AML patients.

Purpose of the Study:

  • To analyze the clinical characteristics of infections in pediatric AML patients undergoing intensive chemotherapy.
  • To identify common pathogens and infection sites during chemotherapy.
  • To provide data for optimizing infection prevention and control strategies.

Main Methods:

  • Retrospective analysis of 56 pediatric AML patients treated between January 2016 and August 2019.
  • Evaluation of infection rates, causative pathogens, and common infection locations during induction and consolidation chemotherapy.
  • Analysis of infection-related mortality.

Main Results:

  • A high overall infection rate (93.4%-96.4%) was observed in pediatric AML patients.
  • The average rate of severe infections was 16.0%, with bloodstream infections being most common, primarily caused by Gram-negative bacteria.
  • Fungal infections occurred in 35.7% of patients, and infection-related mortality was 10.7%.

Conclusions:

  • Pediatric AML patients face a substantial risk of infection throughout chemotherapy.
  • Bloodstream infections represent a significant cause of severe illness and mortality.
  • Proactive use of antifungal agents is recommended to mitigate fungal infections in this vulnerable population.
Abstract

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
568
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
35
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
93
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.5K